U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060794) titled 'Tafenoquine and DHA-piperaquine (TADORE- Plus)' on July 02.
Brief Summary: A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine using a control arm with radical cure given at the end of follow up (delayed radical cure).
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Vivax Malaria
Intervention:
DRUG: Tafenoquine
Tafenoquine in combination with DHA-piperaquine
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Menzies School of Health Research
Disclaimer: Curated by HT Syndication....